SOPHiA GENETICS (SOPH) Operating Leases (2020 - 2025)

SOPHiA GENETICS has disclosed Operating Leases across 6 years of filings, most recently posting $12.6 million for Q4 2025.

• Operating Leases for Q4 2025 came in at $12.6 million, down 13.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $12.6 million (down 13.81% YoY), and the FY2025 annual result was $12.6 million, down 13.81% from the prior year.
• Operating Leases came in at $12.6 million for Q4 2025 at SOPHiA GENETICS, down from $13.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $16.7 million in Q4 2022 to a low of $1.9 million in Q3 2024.
• The 5-year median for Operating Leases is $14.2 million (2024), against an average of $12.9 million.
• Across the five-year window, Operating Leases slumped 87.3% in 2024 and jumped 593.84% in 2025, its largest moves.
• SOPHiA GENETICS's Operating Leases stood at $13.1 million in 2021, then grew by 28.21% to $16.7 million in 2022, then declined by 6.39% to $15.7 million in 2023, then slipped by 6.83% to $14.6 million in 2024, then declined by 13.81% to $12.6 million in 2025.
• The last three Operating Leases figures came in at $12.6 million (Q4 2025), $13.2 million (Q3 2025), and $13.9 million (Q2 2025), per Business Quant data.